{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:57:09Z","timestamp":1782842229522,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004761","name":"the Natural Science Foundation of Henan Province","doi-asserted-by":"crossref","award":["242300420070"],"award-info":[{"award-number":["242300420070"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Open Project of Key Laboratory of the Ministry of Education","award":["2022-MEKLLC-ZD-002"],"award-info":[{"award-number":["2022-MEKLLC-ZD-002"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81902904"],"award-info":[{"award-number":["81902904"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-79123-6","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T10:13:08Z","timestamp":1731147188000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Identification of novel ABCB4 variants and genotype-phenotype correlation in progressive familial intrahepatic cholestasis type 3"],"prefix":"10.1038","volume":"14","author":[{"given":"Senyan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,9]]},"reference":[{"key":"79123_CR1","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1053\/gast.2001.23984","volume":"120","author":"E Jacquemin","year":"2001","unstructured":"Jacquemin, E. et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology. 120, 1448\u20131458. https:\/\/doi.org\/10.1053\/gast.2001.23984 (2001).","journal-title":"Gastroenterology"},{"key":"79123_CR2","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1055\/s-0038-1667299","volume":"38","author":"MC Reichert","year":"2018","unstructured":"Reichert, M. C. & Lammert, F. ABCB4 gene aberrations in human liver disanse: An evolving spectrum. Semin Liver Dis. 38, 299\u2013307. https:\/\/doi.org\/10.1055\/s-0038-1667299 (2018).","journal-title":"Semin Liver Dis."},{"key":"79123_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1055\/s-0030-1253223","volume":"30","author":"A Davit-Spraul","year":"2010","unstructured":"Davit-Spraul, A. et al. The spectrum of liver diseases related to ABCB4 gene mutations: pathophysiology and clinical aspects. Semin Liver Dis. 30, 134\u2013146. https:\/\/doi.org\/10.1055\/s-0030-1253223 (2010).","journal-title":"Semin Liver Dis."},{"key":"79123_CR4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.dld.2019.04.013","volume":"51","author":"G Vitale","year":"2019","unstructured":"Vitale, G. et al. Familial intrahepatic cholestasis: New and wide perspectives. Dig. Liver Dis. 51, 922\u2013933. https:\/\/doi.org\/10.1016\/j.dld.2019.04.013 (2019).","journal-title":"Dig. Liver Dis."},{"key":"79123_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1073\/pnas.95.1.282","volume":"95","author":"JM de Vree","year":"1998","unstructured":"de Vree, J. M. et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc. Natl. Acad. Sci. USA. 95, 282\u2013287. https:\/\/doi.org\/10.1073\/pnas.95.1.282 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"79123_CR6","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","volume":"75","author":"JJM Smit","year":"1993","unstructured":"Smit, J. J. M., Schinkel, A. H. & Elferink, O. Homozygous disruption of the murine mdr2 P-Glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell. 75, 451\u2013462. https:\/\/doi.org\/10.1016\/0092-8674(93)90380-9 (1993).","journal-title":"Cell"},{"key":"79123_CR7","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/0092-8674(94)90446-4","volume":"77","author":"S Ruetz","year":"1994","unstructured":"Ruetz, S. & Gros, P. Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell. 77, 1071\u20131081. https:\/\/doi.org\/10.1016\/0092-8674(94)90446-4 (1994).","journal-title":"Cell"},{"key":"79123_CR8","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1053\/j.gastro.2005.08.052","volume":"130","author":"RPJ Oude Elferink","year":"2006","unstructured":"Oude Elferink, R. P. J., Paulusma, C. C. & Groen, A. K. Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases. Gastroenterology. 130, 908\u2013925. https:\/\/doi.org\/10.1053\/j.gastro.2005.08.052 (2006).","journal-title":"Gastroenterology"},{"key":"79123_CR9","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1053\/j.gastro.2013.03.053","volume":"144","author":"GM Hirschfield","year":"2013","unstructured":"Hirschfield, G. M. et al. The genetics of complex cholestatic disorders. Gastroenterology. 144, 1357\u20131374. https:\/\/doi.org\/10.1053\/j.gastro.2013.03.053 (2013).","journal-title":"Gastroenterology"},{"key":"79123_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jhep.2015.02.023","volume":"62","author":"U Beuers","year":"2015","unstructured":"Beuers, U. et al. New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond. J. Hepatol. 62, 25\u2013S37. https:\/\/doi.org\/10.1016\/j.jhep.2015.02.023 (2015).","journal-title":"J. Hepatol."},{"key":"79123_CR11","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1002\/hep.30773","volume":"70","author":"SM Siew","year":"2019","unstructured":"Siew, S. M. et al. Prevention of cholestatic liver disease and reduced tumorigenicity in a murine model of PFIC type 3 using hybrid AAV-piggyBac gene therapy. Hepatology. 70, 2047\u20132061. https:\/\/doi.org\/10.1002\/hep.30773 (2019).","journal-title":"Hepatology"},{"key":"79123_CR12","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1016\/j.jhep.2020.12.010","volume":"74","author":"G Wei","year":"2021","unstructured":"Wei, G. et al. Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB\/c.Abcb4-\/- mouse model of PFIC3. J. Hepatol. 74, 1416\u20131428. https:\/\/doi.org\/10.1016\/j.jhep.2020.12.010 (2021).","journal-title":"J. Hepatol."},{"key":"79123_CR13","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1097\/01.tp.0000282869.94152.4f","volume":"84","author":"C Englert","year":"2007","unstructured":"Englert, C. et al. Liver transplantation in children with progressive familial intrahepatic cholestasis. Transplantation. 84, 1361\u20131363. https:\/\/doi.org\/10.1097\/01.tp.0000282869.94152.4f (2007).","journal-title":"Transplantation"},{"key":"79123_CR14","doi-asserted-by":"publisher","unstructured":"Saleem, K. et al. Evaluation of a novel missense mutation in ABCB4 gene causing progressive familial intrahepatic cholestasis type 3. Dis Markers 6292818 (2020). (2020). https:\/\/doi.org\/10.1155\/2020\/6292818","DOI":"10.1155\/2020\/6292818"},{"key":"79123_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards, S. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 17, 405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30 (2015).","journal-title":"Genet. Med."},{"key":"79123_CR16","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2009.86","volume":"4","author":"P Kumar","year":"2009","unstructured":"Kumar, P., Henikoff, S. & Ng, P. C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073\u20131081. https:\/\/doi.org\/10.1038\/nprot.2009.86 (2009).","journal-title":"Nat. Protoc."},{"key":"79123_CR17","doi-asserted-by":"publisher","first-page":"Unit720","DOI":"10.1002\/0471142905.hg0720s76","volume":"7","author":"I Adzhubei","year":"2013","unstructured":"Adzhubei, I., M Jordan, D. & R Sunyaev, S. Predicting functional effect of human missense mutations using PolyPhen-2. Curr. Protoc. Hum. Genet. Chap. 7, Unit720. https:\/\/doi.org\/10.1002\/0471142905.hg0720s76 (2013).","journal-title":"Curr. Protoc. Hum. Genet. Chap"},{"key":"79123_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nmeth0810-575","volume":"7","author":"JM Schwarz","year":"2010","unstructured":"Schwarz, J. M. et al. MutationTaster evaluates disease-causing potential of sequence alterations. Nat. Methods. 7, 575\u2013576. https:\/\/doi.org\/10.1038\/nmeth0810-575 (2010).","journal-title":"Nat. Methods"},{"key":"79123_CR19","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","volume":"31","author":"Y Choi","year":"2015","unstructured":"Choi, Y. & Chan, A. P. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 31, 2745\u20132747. https:\/\/doi.org\/10.1093\/bioinformatics\/btv195 (2015).","journal-title":"Bioinformatics"},{"key":"79123_CR20","doi-asserted-by":"publisher","unstructured":"O. Desmet, F. et al. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 37 (e67). https:\/\/doi.org\/10.1093\/nar\/gkp215 (2009).","DOI":"10.1093\/nar\/gkp215"},{"key":"79123_CR21","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1093\/molbev\/msab120","volume":"38","author":"K Tamura","year":"2021","unstructured":"Tamura, K., Stecher, G. & Kumar, S. MEGA11: molecular evolutionary genetics analysis version 11. Mol. Biol. Evol. 38, 3022\u20133027. https:\/\/doi.org\/10.1093\/molbev\/msab120 (2021).","journal-title":"Mol. Biol. Evol."},{"key":"79123_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cld.2018.06.003","volume":"22","author":"LN Bull","year":"2018","unstructured":"Bull, L. N. & Thompson, R. J. Progressive familial intrahepatic cholestasis. Clin. Liver Dis. 22, 657\u2013669. https:\/\/doi.org\/10.1016\/j.cld.2018.06.003 (2018).","journal-title":"Clin. Liver Dis."},{"key":"79123_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00424-006-0062-9","volume":"453","author":"RPJ Oude Elferink","year":"2007","unstructured":"Oude Elferink, R. P. J. & Paulusma, C. C. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch. 453, 601\u2013610. https:\/\/doi.org\/10.1007\/s00424-006-0062-9 (2007).","journal-title":"Pflugers Arch."},{"key":"79123_CR24","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/hep.510250303","volume":"25","author":"E Jacquemin","year":"1997","unstructured":"Jacquemin, E. et al. Ursodeoxycholic acid therapy in pediatric patients with progressive familial intrahepatic cholestasis. Hepatology. 25, 519\u2013523. https:\/\/doi.org\/10.1002\/hep.510250303 (1997).","journal-title":"Hepatology"},{"key":"79123_CR25","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1111\/j.1399-0012.2010.01368.x","volume":"25","author":"T Hori","year":"2011","unstructured":"Hori, T. et al. Progressive familial intrahepatic cholestasis: a single-center experience of living-donor liver transplantation during two decades in Japan. Clin. Transpl. 25, 776\u2013785. https:\/\/doi.org\/10.1111\/j.1399-0012.2010.01368.x (2011).","journal-title":"Clin. Transpl."},{"key":"79123_CR26","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/hep.20682","volume":"41","author":"V Keitel","year":"2005","unstructured":"Keitel, V. et al. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis. Hepatology. 41, 1160\u20131172. https:\/\/doi.org\/10.1002\/hep.20682 (2005).","journal-title":"Hepatology"},{"key":"79123_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1042\/BSE0500043","volume":"50","author":"JK Zolnerciks","year":"2011","unstructured":"Zolnerciks, J. K. et al. Structure of ABC transporters. Essays Biochem. 50, 43\u201361. https:\/\/doi.org\/10.1042\/BSE0500043 (2011).","journal-title":"Essays Biochem."},{"key":"79123_CR28","first-page":"17S","volume":"12","author":"AF Hofmann","year":"1990","unstructured":"Hofmann, A. F. Bile acid secretion, bile flow and biliary lipid secretion in humans. Hepatology. 12, 17S\u201322S (1990). discussion 22S-25S.","journal-title":"Hepatology"},{"key":"79123_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jceh.2013.10.005","volume":"4","author":"A Srivastava","year":"2014","unstructured":"Srivastava, A. Progressive familial intrahepatic cholestasis. J. Clin. Exp. Hepatol. 4, 25\u201336. https:\/\/doi.org\/10.1016\/j.jceh.2013.10.005 (2014).","journal-title":"J. Clin. Exp. Hepatol."},{"key":"79123_CR30","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1111\/j.1478-3231.2008.01914.x","volume":"29","author":"KE Nakken","year":"2009","unstructured":"Nakken, K. E. et al. ABCB4 sequence variations in young adults with cholesterol gallstone disease. Liver Int. 29, 743\u2013747. https:\/\/doi.org\/10.1111\/j.1478-3231.2008.01914.x (2009).","journal-title":"Liver Int."},{"key":"79123_CR31","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1111\/LIV.14662","volume":"40","author":"E de Vries","year":"2020","unstructured":"de Vries, E. et al. Carriers of ABCB4 gene variants show a mild clinical course, but impaired quality of life and limited risk for cholangiocarcinoma. Liver Int. 40, 3042\u20133050. https:\/\/doi.org\/10.1111\/LIV.14662 (2020).","journal-title":"Liver Int."},{"key":"79123_CR32","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/liv.12910","volume":"36","author":"R Gordo-Gilart","year":"2016","unstructured":"Gordo-Gilart, R. et al. Heterozygous ABCB4 mutations in children with cholestatic liver disease. Liver Int. 36, 258\u2013267. https:\/\/doi.org\/10.1111\/liv.12910 (2016).","journal-title":"Liver Int."},{"key":"79123_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1111\/j.1478-3231.2009.02148.x","volume":"30","author":"R Poupon","year":"2009","unstructured":"Poupon, R. et al. Combined features of low phospholipid-associated cholelithiasis and progressive familial intrahepatic cholestasis 3. Liver Int. 30, 327\u2013331. https:\/\/doi.org\/10.1111\/j.1478-3231.2009.02148.x (2009).","journal-title":"Liver Int."},{"key":"79123_CR34","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/hep.28929","volume":"65","author":"JL Delaunay","year":"2017","unstructured":"Delaunay, J. L. et al. Functional defect of variants in the ATP-binding sites of ABCB4 and their rescue by the CFTR potentiator, ivacaftor (VX-770). Hepatology. 65, 560\u2013570. https:\/\/doi.org\/10.1002\/hep.28929 (2017).","journal-title":"Hepatology"},{"key":"79123_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1136\/gutjnl-2014-306896","volume":"64","author":"R Gordo-Gilart","year":"2015","unstructured":"Gordo-Gilart, R. et al. Functional analysis of ABCB4 mutations relates clinical outcomes of progressive familial intrahepatic cholestasis type 3 to the degree of MDR3 floppase activity. Gut. 64, 147\u2013155. https:\/\/doi.org\/10.1136\/gutjnl-2014-306896 (2015).","journal-title":"Gut"},{"key":"79123_CR36","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.jhep.2009.11.012","volume":"52","author":"JM Stapelbroek","year":"2010","unstructured":"Stapelbroek, J. M. et al. Liver disease associated with canalicular transport defects: current and future therapies. J. Hepatol. 52, 258\u2013271. https:\/\/doi.org\/10.1016\/j.jhep.2009.11.012 (2010).","journal-title":"J. Hepatol."},{"key":"79123_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1053\/j.gastro.2006.10.034","volume":"132","author":"C Liu","year":"2007","unstructured":"Liu, C. et al. Novel resequencing chip customized to diagnose mutations in patients with inherited syndromes of intrahepatic cholestasis. Gastroenterology. 132, 119\u2013126. https:\/\/doi.org\/10.1053\/j.gastro.2006.10.034 (2007).","journal-title":"Gastroenterology"},{"key":"79123_CR38","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jhep.2019.03.021","volume":"71","author":"SJ Aronson","year":"2019","unstructured":"Aronson, S. J. et al. Liver-directed gene therapy results in long-term correction of progressive familial intrahepatic cholestasis type 3 in mice. J. Hepatol. 71, 153\u2013162. https:\/\/doi.org\/10.1016\/j.jhep.2019.03.021 (2019).","journal-title":"J. Hepatol."},{"key":"79123_CR39","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.jhep.2021.09.033","volume":"76","author":"ND Weber","year":"2022","unstructured":"Weber, N. D., Mart\u00ednez-Garc\u00eda, J. & Gonz\u00e1lez-Aseguinolaza, G. Comment on Synthetic human ABCB4 mRNA therapy rescues severe liver disease phenotype in a BALB\/c.Abcb4-\/- mouse model of PFIC3. J. Hepatol. 76, 749\u2013751. https:\/\/doi.org\/10.1016\/j.jhep.2021.09.033 (2022).","journal-title":"J. Hepatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79123-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79123-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79123-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T15:07:42Z","timestamp":1731424062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-79123-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,9]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["79123"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-79123-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,9]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University (Approval No. 2022-KY-0826-001), and all family members or legal guardians of patients under 18 years of age signed a written informed consent. The data in this study were anonymized, or treated confidentially, and did not affect the diagnosis or treatment of the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27381"}}